4月24日，赛诺菲发布2025年第一季度业绩。财报显示，第一季度销售额为99亿欧元，同比增长11%，市场预期为96.8亿欧元；第一季度业务每股收益为1.79欧元，市场预期为1.67欧元。
第一季度生物制药业务营业收入为28.9亿欧元，同比增长21%，市场预期为27.6亿欧元。
第一季度研发费用为18.1亿欧元，同比增长8.3%，市场预期为17.2亿欧元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.